| Identification |
| Name: | 2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride, (4R,4aS,5aS,6S,12aS)- (9CI) |
| Synonyms: | 2-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride, [4R-(4a,4ab,5ab,6a,12ab)]-; 4-Epichlortetracyclinehydrochloride |
| CAS: | 101342-45-4 |
| Molecular Formula: | C22H23 Cl N2 O8 . Cl H |
| Molecular Weight: | 515.34 |
| InChI: | InChI=1/C22H23ClN2O8.ClH/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21;/h4-5,7-8,15,26,28-29,32-33H,6H2,1-3H3,(H2,24,31);1H/t7?,8?,15-,21+,22?;/m1./s1 |
| Molecular Structure: |
 |
| Properties |
| Usage: | A Tetracycline derivative. It is a metalloprotease inhibitor, used in treating tissue destructive diseases and cancer |
| Safety Data |
| |
 |
